Company: BSX
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000885725-25-000011
Chunk: 156

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 156
---
 for identical assets or liabilities.•Level 2 – Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.•Level 3 – Inputs to the valuation methodology are unobservable inputs based on management’s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.

91

Assets and liabilities measured at fair value on a recurring basis consist of the following:As of December 31, 2024December 31, 2023(in millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3TotalAssets        Money market funds and time deposits$120 $— $— $120 $454 $— $— $454 Publicly-held securities19 — — 19 18 — — 18 Hedging instruments— 384 — 384 — 266 — 266 Licensing arrangements— — 24 24 — — 77 77  $139 $384 $24 $547 $472 $266 $77 $816 Liabilities        Hedging instruments$— $990 $— $990 $— $1,050 $— $1,050 Contingent consideration liability— — 171 171 — — 404 404 Licensing arrangements— — 33 33 — — 90 90  $— $990 $203 $1,194 $— $1,050 $494 $1,545 Our investments in money market funds and time deposits are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. These investments are classified as Cash and cash equivalents or Other current assets within our accompanying consolidated balance sheets, in accordance with GAAP and our accounting policies. In addition to $120 million invested in money market funds and time deposits as of December 31, 2024 and $454 million as of December 31, 2023, we held $364 million in interest-bearing and non-interest-bearing bank accounts as of December 31, 2024 and $411 million as of December 31, 2023.Our recurring fair value measurements using Level 3 inputs include those related to our contingent consideration liability. Refer